[1] |
国家卫生健康委办公厅. 胰腺癌诊疗指南(2022年版)[J]. 临床肝胆病杂志, 2022, 38(5): 1006-1015. DOI: 10.3969/j.issn.1001-5256.2022.05.007.
|
[2] |
中国医师协会放射肿瘤治疗医师分会. 胰腺癌立体定向放疗(放射外科)指南[J]. 国际肿瘤学杂志, 2021, 48(11): 643-648. DOI: 10.3760/cma.j.cn371439-20210621-00128.
|
[3] |
Javadi S, Karbasian N, Bhosale P, et al. Imaging findings of recurrent pancreatic cancer following resection[J]. Abdom Radiol (NY), 2018, 43(2): 489-496. DOI: 10.1007/s00261-017-1397-8.
pmid: 29198001
|
[4] |
Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries[J]. Lancet Glob Health, 2018, 6(5): e555-e567. DOI: 10.1016/S2214-109X(18)30127-X.
|
[5] |
Rocha FG. Landmark series: immunotherapy and targeted therapy for pancreatic cancer[J]. Ann Surg Oncol, 2021, 28(3): 1400-1406. DOI: 10.1245/s10434-020-09367-9.
pmid: 33386541
|
[6] |
Zhou CF, Ma J, Huang L, et al. Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1[J]. Oncogene, 2019, 38(8): 1256-1268. DOI: 10.1038/s41388-018-0511-x.
|
[7] |
Kim H, Kwon W, Kim JR, et al. Recurrence patterns after pancreaticoduodenectomy for ampullary cancer[J]. J Hepatobiliary Pancreat Sci, 2019, 26(5): 179-186. DOI: 10.1002/jhbp.618.
pmid: 30849209
|
[8] |
Agalar C, Aysal A, Unek T, et al. The role of log odds of positive lymph nodes in predicting the survival after resection for ampullary adenocarcinoma[J]. Pathol Oncol Res, 2020, 26(1): 467-473. DOI: 10.1007/s12253-019-00584-6.
pmid: 30693420
|
[9] |
Jang JY, Kang JS, Han Y, et al. Long-term outcomes and recurrence patterns of standard versus extended pancreatectomy for pancreatic head cancer: a multicenter prospective randomized controlled study[J]. J Hepatobiliary Pancreat Sci, 2017, 24(7): 426-433. DOI: 10.1002/jhbp.465.
|
[10] |
徐业成, 傅德良. 胰腺癌淋巴结转移研究进展[J]. 肝胆外科杂志, 2022, 30(1): 76-80. DOI: 10.3969/j.issn.1006-4761.2022.01.022.
|
[11] |
Pedrazzoli S. Surgical treatment of pancreatic cancer: currently debated topics on morbidity, mortality, and lymphadenectomy[J]. Surg Oncol, 2022, 45: 101858. DOI: 10.1016/j.suronc.2022.101858.
|
[12] |
Ignjatovic I, Knezevic S, Knezevic D, et al. Standard versus extended lymphadenectomy in radical surgical treatment for pancreatic head carcinoma[J]. J BUON, 2017, 22(1): 232-238.
pmid: 28365959
|
[13] |
Warschkow R, Tsai C, Köhn N, et al. Role of lymphadenectomy, adjuvant chemotherapy, and treatment at high-volume centers in patients with resected pancreatic cancer — a distinct view on lymph node yield[J]. Langenbecks Arch Surg, 2020, 405(1): 43-54. DOI: 10.1007/s00423-020-01859-2.
|
[14] |
Lino-Silva LS, Salcedo-Hernández RA, Segales-Rojas P, et al. Comparison of 3 ways of dissecting the pancreatoduodenectomy specimen and their impact in the lymph node count and the lymph node metastatic ratio[J]. Int J Surg Pathol, 2018, 26(8): 707-713. DOI: 10.1177/1066896918780343.
pmid: 29873282
|
[15] |
Kado T, Tomimaru Y, Kobayashi S, et al. Prognostic impact of gastroduodenal artery involvement in cancer of the pancreatic head[J]. Ann Surg Oncol, 2023, 30(4): 2413-2421. DOI: 10.1245/s10434-022-12759-8.
|
[16] |
Lu Y, Jiang J, Ren C. The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: a meta-analysis[J]. PLoS One, 2020, 15(4): e0230979. DOI: 10.1371/journal.pone.0230979.
|
[17] |
Velazquez-Caldelas TE, Alcalá-Corona SA, Espinal-Enríquez J, et al. Unveiling the link between inflammation and adaptive immunity in breast cancer[J]. Front Immunol, 2019, 10: 56. DOI: 10.3389/fimmu.2019.00056.
pmid: 30761130
|
[18] |
Tang J, Yang Z, Wang Z, et al. Foxp3 is correlated with VEGF-C expression and lymphangiogenesis in cervical cancer[J]. World J Surg Oncol, 2017, 15(1): 173. DOI: 10.1186/s12957-017-1221-5.
pmid: 28923073
|
[19] |
Luchini C, Veronese N, Nottegar A, et al. Perineural invasion is a strong prognostic moderator in ampulla of vater carcinoma: a meta-analysis[J]. Pancreas, 2019, 48(1): 70-76. DOI: 10.1097/MPA.0000000000001194.
|
[20] |
El Nakeeb A, El Sorogy M, Ezzat H, et al. Predictors of long-term survival after pancreaticoduodenectomy for peri-ampullary adenocarcinoma: a retrospective study of 5-year survivors[J]. Hepatobiliary Pancreat Dis Int, 2018, 17(5): 443-449. DOI: 10.1016/j.hbpd.2018.08.004.
|
[21] |
王媛媛, 蒙博, 王莹莹. 影响胰腺癌切除术后患者预后的相关危险因素分析[J]. 实用癌症杂志, 2023, 38(1): 142-144, 151. DOI: 10.3969/j.issn.1001-5930.2023.01.041.
|
[22] |
保吉红, 海华, 党雅莹. 胰头癌患者胰十二指肠切除术后复发的危险因素[J]. 实用癌症杂志, 2022, 37(6): 968-970. DOI: 10.3969/j.issn.1001-5930.2022.06.028.
|